XOMA ROYALTY Trademark

Trademark Overview


On Thursday, March 28, 2024, a trademark application was filed for XOMA ROYALTY with the United States Patent and Trademark Office. The USPTO has given the XOMA ROYALTY trademark a serial number of 98473912. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, October 17, 2024. This trademark is owned by XOMA (US) LLC. The XOMA ROYALTY trademark is filed in the Insurance & Financial Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Financial services, namely, financing related to intellectual property portfolios; Financial services, namely, financing of pharmaceutical, drug, and medical device development; Financial services, namely, providing capital to others by monetizing royalty streams and acquiring revenue interests relating to the sale of products; Financial services, namely, funding through debt-like structures, the development and commercialization of products; Financial services, namely, providing non-dilutive capital to counterparties, including through the purchase of revenue interests and the use of debt-like structures; Equity capital investment

licensing of intellectual property; licensing of pharmaceutical, biopharmaceutical, medicine, and chemical products and technology

pharmaceutical research and development
xoma royalty

General Information


Serial Number98473912
Word MarkXOMA ROYALTY
Filing DateThursday, March 28, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, October 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesFinancial services, namely, financing related to intellectual property portfolios; Financial services, namely, financing of pharmaceutical, drug, and medical device development; Financial services, namely, providing capital to others by monetizing royalty streams and acquiring revenue interests relating to the sale of products; Financial services, namely, funding through debt-like structures, the development and commercialization of products; Financial services, namely, providing non-dilutive capital to counterparties, including through the purchase of revenue interests and the use of debt-like structures; Equity capital investment
Goods and Serviceslicensing of intellectual property; licensing of pharmaceutical, biopharmaceutical, medicine, and chemical products and technology
Goods and Servicespharmaceutical research and development

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, March 28, 2024
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 28, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 28, 2024
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXOMA (US) LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEmeryville, CA 64908

Trademark Events


Event DateEvent Description
Friday, March 29, 2024NEW APPLICATION ENTERED
Friday, August 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 9, 2024ASSIGNED TO EXAMINER
Thursday, October 17, 2024NON-FINAL ACTION WRITTEN
Thursday, October 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 17, 2024NON-FINAL ACTION E-MAILED